MAVUPHARMA
Mavupharma is developing non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.
MAVUPHARMA
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2016-01-01
Address:
Kirkland, Washington, United States
Country:
United States
Website Url:
http://www.mavupharma.com
Total Employee:
1+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
20 M USD
Technology used in webpage:
SPF Font Awesome Apache Microsoft Exchange Online Office 365 Mail Linode
Current Advisors List
Current Employees Featured
Founder
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - Mavupharma
Alpine BioVentures
Alpine BioVentures investment in Series A - Mavupharma
